Terms: = Germ cell tumor AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS
108 results:
1. Quercetin Impairs the Growth of Uveal Melanoma cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract] [Full Text] [Related]
2. Divergent local and systemic antitumor response in primary uveal melanomas.
Lucibello F; Lalanne AI; Le Gac AL; Soumare A; Aflaki S; Cyrta J; Dubreuil L; Mestdagh M; Salou M; Houy A; Ekwegbara C; Jamet C; Gardrat S; Le Ven A; Bernardeau K; Cassoux N; Matet A; Malaise D; Pierron G; Piperno-Neumann S; Stern MH; Rodrigues M; Lantz O
J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38563818
[TBL] [Abstract] [Full Text] [Related]
3. INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas.
Elbatsh AMO; Amin-Mansour A; Haberkorn A; Textor C; Ebel N; Renard E; Koch LM; Groenveld FC; Piquet M; Naumann U; Ruddy DA; Romanet V; Martínez Gómez JM; Shirley MD; Wipfli P; Schnell C; Wartmann M; Rausch M; Jager MJ; Levesque MP; Maira SM; Manchado E
Nat Cancer; 2024 Mar; 5(3):481-499. PubMed ID: 38233483
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell profiling of MC1R-inhibited melanocytes.
Berns HM; Watkins-Chow DE; Lu S; Louphrasitthiphol P; Zhang T; Brown KM; Moura-Alves P; Goding CR; Pavan WJ
Pigment Cell Melanoma Res; 2024 Mar; 37(2):291-308. PubMed ID: 37972124
[TBL] [Abstract] [Full Text] [Related]
5. The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma.
Issam Salah NEI; Marnissi F; Lakhdar A; Karkouri M; ElBelhadji M; Badou A
Front Immunol; 2023; 14():1225140. PubMed ID: 37662962
[TBL] [Abstract] [Full Text] [Related]
6. Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies.
Jakubechova J; Smolkova B; Furdova A; Demkova L; Altanerova U; Nicodemou A; Zeleznikova T; Klimova D; Altaner C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629139
[TBL] [Abstract] [Full Text] [Related]
7. Intracellular mechanics and tbx3 expression jointly dictate the spreading mode of melanoma cells in 3D environments.
Higgins G; Higgins F; Peres J; Lang DM; Abdalrahman T; Zaman MH; Prince S; Franz T
Exp Cell Res; 2023 Jul; 428(2):113633. PubMed ID: 37172754
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.
Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M
Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079
[TBL] [Abstract] [Full Text] [Related]
9. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
[TBL] [Abstract] [Full Text] [Related]
10. The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.
Jia SQ; Zhuo R; Zhang ZM; Yang Y; Tao YF; Wang JW; Li XL; Xie Y; Li G; Wu D; Chen YL; Yu JJ; Feng CX; Li ZH; Zhou RF; Yang RD; Yang PC; Zhou B; Wan XM; Wu YM; Jiao WY; Zhou NN; Fang F; Pan J
J Immunol Res; 2022; 2022():7945884. PubMed ID: 36438198
[TBL] [Abstract] [Full Text] [Related]
11. Post-enucleation outcomes of patients with uveal melanoma in Scotland.
Sarode D; McClay T; Roberts F; Connolly J; Cauchi P; Chadha V
Eye (Lond); 2023 Apr; 37(5):988-994. PubMed ID: 36266538
[TBL] [Abstract] [Full Text] [Related]
12. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.
Li X; Moreira DC; Bag AK; Qaddoumi I; Acharya S; Chiang J
Neuro Oncol; 2023 Apr; 25(4):750-760. PubMed ID: 36260562
[TBL] [Abstract] [Full Text] [Related]
13. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Elmali A; Yilmaz MT; Koc I; Deliktas O; Gumeler E; Cengiz M; Zorlu F
Radiother Oncol; 2022 Nov; 176():39-45. PubMed ID: 36184996
[TBL] [Abstract] [Full Text] [Related]
14. [The effect of sex hormones and pregnancy on development and progression of uveal melanoma].
Likhvantseva VG; Ovanesyan VE
Vestn Oftalmol; 2022; 138(3):110-117. PubMed ID: 35801889
[TBL] [Abstract] [Full Text] [Related]
15. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract] [Full Text] [Related]
16. Vascular Lakes in Uveal Melanoma and Their Association With Outcome.
Jones H; Kalirai H; Taktak A; Chen K; Coupland SE
Transl Vis Sci Technol; 2022 Mar; 11(3):32. PubMed ID: 35348598
[TBL] [Abstract] [Full Text] [Related]
17. Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.
Freeman SS; Sade-Feldman M; Kim J; Stewart C; Gonye ALK; Ravi A; Arniella MB; Gushterova I; LaSalle TJ; Blaum EM; Yizhak K; Frederick DT; Sharova T; Leshchiner I; Elagina L; Spiro OG; Livitz D; Rosebrock D; Aguet F; Carrot-Zhang J; Ha G; Lin Z; Chen JH; Barzily-Rokni M; Hammond MR; Vitzthum von Eckstaedt HC; Blackmon SM; Jiao YJ; Gabriel S; Lawrence DP; Duncan LM; Stemmer-Rachamimov AO; Wargo JA; Flaherty KT; Sullivan RJ; Boland GM; Meyerson M; Getz G; Hacohen N
Cell Rep Med; 2022 Feb; 3(2):100500. PubMed ID: 35243413
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
[TBL] [Abstract] [Full Text] [Related]
19. Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis.
Buonanno F; Conson M; de Almeida Ribeiro C; Oliviero C; Itta F; Liuzzi R; Pacelli R; Cella L; Clemente S
Radiother Oncol; 2022 Jan; 166():15-25. PubMed ID: 34774654
[TBL] [Abstract] [Full Text] [Related]
20. Fractionated stereotactic radiotherapy for uveal melanoma: Long-term outcome and control rates.
van Beek JGM; van Rij CM; Baart SJ; Yavuzyigitoglu S; Bergmann MJ; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2022 Aug; 100(5):511-519. PubMed ID: 34529346
[TBL] [Abstract] [Full Text] [Related]
[Next]
